SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Big Sponsors > Eli Lilly

Drug formulary looks to accelerate clinical trial start up

12-Jan-2017 - The “NCI Formulary” enables investigators to obtain investigational agents for testing in new preclinical or clinical studies.

QuintilesIMS leading Big Pharma firms in oncology collaboration

22-Nov-2016 - The new collaborative initiative will be led by QuintilesIMS, with founding partners including Bristol-Myers Squibb, Eli Lilly and Company, Merck KGaA, and Pfizer.

Dispatches from BIO 2016

Drug development in space: how microgravity enables pharma

15-Jun-2016 - Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the next year – with several implications for pharma back on Earth.

WuXi inks CV development and manufacture deal with Eli Lilly in China

12-Nov-2015 - WuXi PharmaTech will develop and manufacture a cardiovascular candidate for Eli Lilly in China through a strategic collaboration.

Lilly ends Alzheimer’s study contract with UCSD as California judge steps in

06-Aug-2015 - Eli Lilly on Tuesday cut ties with the University of California, San Diego (UCSD) as a legal battle between UCSD and the University of Southern California (USC) continues over the control of...

Expansions of in-house R&D will have no impact on CROs, say Pfizer and Lilly

30-Jul-2015 - Despite expanding their in-house R&D facilities, both Pfizer and Eli Lilly say they remain committed to using CROs.

Gilead's reliance on CMOs gives firm 'flexibility' says CFO

21-May-2015 - Reliance on CMOs and CROs has allowed the flexibility to make Gilead a top 10 pharma firm, and the use of third-parties will remain part of its strategy according to...

Bio-CMO sector to grow over 40% on Big Biopharma's burgeoning pipelines

24-Apr-2015 - Cheaper disposable manufacturing techs and increased demand for outsourced production will see more CMOs enter the contracting sector according to HighTech Business Decisions

Update

TransCelerate launches two new initiatives to accelerate clinical trials

10-Apr-2015 - Industry group TransCelerate BioPharma has established two new global initiatives around placebo and standard of care data sharing, and electronic labels for clinical trials – both of which aim to...

Lilly inks $450m oncology drug development collaboration in China

20-Mar-2015 - Eli Lilly and China biotech Innovent Biologics will collaborate to develop at least three cancer treatments over the next decade. 

Exclusive interview

Preclinical prices improving says Huntingdon CEO; firm is mulling US capacity expansion

05-Mar-2015 - Higher capacity utilization is improving prices across the non-clinical research sector according to Huntingdon Life Sciences CEO Brian Cass, who told Outsourcing-pharma.com the preclinical CRO may add scale to US...

Dispatches from InformEx

What helps an outsourcing partnership? Be up front about the bad news

06-Feb-2015 - When it comes to forging solid relationships between CMOs (contract manufacturing organizations) and drug developers, one thing is clear: deviations will occur.

Novartis to close Puerto Rico plant and outsource to Eli Lilly

19-Jan-2015 - Novartis will close an OTC plant in Puerto Rico by 2019 and transfer manufacturing and packaging actives to sites in the US and facilities operated by Eli Lilly and Virbac.

Covance says investor lawsuit seeking to derail LabCorp acquisition ‘without merit’

15-Dec-2014 - A Covance investor is raising questions over Goldman Sachs’ involvement in providing advice to the CRO’s board, which recently accepted a $6.1bn takeover offer from industry peer LabCorp.

INC Research expands partnership with Society for Clinical Research Sites

08-Dec-2014 - INC Research has expanded its partnership with the Society for Clinical Research Sites (SCRS) through the end of 2015 to become the first organization to support SCRS' new member Scholarship...

CMO use to grow despite Big Biopharma's in-house spend, say experts

02-Dec-2014 - Third-party manufacturers anxious about Big Biopharma investments and downbeat industry reports can relax as experts concur “it’s a time of growth for biopharmaceutical outsourcing.”

Mercks & recreation? The pharma industry and the sporting world

03-Nov-2014 - In an Outsourcing-Pharma sporting special, we reveal why GSK will not be at the Rio Olympics, why PPD has renewed its ironman triathlon sponsorship, and what became of BMS' partnership with Lance...

Exclusive Interview

Lilly focuses in-house as manufacturing becomes more complex

27-May-2014 - Eli Lilly is maintaining greater in-house control as manufacturing processes become more complex, whilst MSD is leveraging external over-capacity to fulfil its needs, the firms told Outsourcing-Pharma.com during a recent...

Lilly: Performance Metrics Key to CMO Management

03-Jul-2013 - Performance monitoring should be applied equally to external manufacturing as internal operations, says Eli Lilly.

Theft Down Since $80m Lilly Heist as Industry Shares Intelligence

03-Jul-2013 - Collaboration and intelligence sharing has seen pharmaceutical cargo theft decline heavily since Lilly fell prey to an $80m heist in 2010, says industry expert.

Lilly Adds Another to List of Companion Diagnostic Contractors

29-May-2013 - Eli Lilly has selected another contractor to help develop companion diagnostics for its oncology pipeline.

Lilly drives expansion at Rexam's insulin pen manufacturing plant

07-Feb-2013 - Rexam says that expansion of its French plant is led by Lilly and the growing demand for insulin delivery products.

Is Eli Lilly distancing itself from outsourcing?

05-Nov-2012 - Eli Lilly is bringing more production in-house after investing $140m in the expansion of its US insulin site.

Covance inks alliances with Bayer and Eli Lilly

31-May-2012 - Covance has inked deals to provide preclinical services to Eli Lilly’s diabetes operations in China and late-stage support to Bayer Healthcare.

Jubilant buys Lilly out of early-phase JV

26-Jan-2012 - Jubilant Life Sciences has bought US drugmaker Eli Lilly’s stake in the early-stage development focused JV the firms set up in 2008.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...